Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | 26.217 | 24.932 | 17.601 | - |
| Net Profit Margin | -613.162 | -419.395 | -193.561 | - |
| Debt to Asset Ratio | 134.392 | 154.769 | 143.744 | 133.885 |
| Cash Ratio | 136.114 | 135.385 | 104.99 | 93.297 |
| Quick Ratio | 292.007 | 273.252 | 216.384 | 262.055 |
| Current Ratio | 292.007 | 273.252 | 216.384 | 262.055 |